Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Published in
American Journal of Kidney Diseases, September 2021
Pharmacology, Toxicology and Pharmaceutical Science
2
11%
Biochemistry, Genetics and Molecular Biology
1
5%
Nursing and Health Professions
1
5%
Agricultural and Biological Sciences
1
5%
Other
0
0%
Unknown
10
53%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 40. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2022.
All research outputs
#1,332,084
of 34,842,917 outputs
Outputs from American Journal of Kidney Diseases
#560
of 7,441 outputs
Outputs of similar age
#24,287
of 465,974 outputs
Outputs of similar age from American Journal of Kidney Diseases
#25
of 76 outputs
Altmetric has tracked 34,842,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,441 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 465,974 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.